olmesartan medoxomil has been researched along with Cardiovascular Stroke in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (85.71) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arai, K; Homma, T; Ikeda, M; Manabe, K; Mizuno, M; Sada, T; Sonoda, H | 1 |
| Iwao, H; Izumi, Y; Kim, S; Nakamura, Y; Omura, T; Takeuchi, K; Yoshida, K; Yoshikawa, J; Yoshiyama, M | 1 |
| Ichinohasama, R; Kagaya, Y; Ninomiya, M; Shirato, K; Sugie, T; Takahashi, C; Takahashi, J; Takeda, M; Tezuka, F; Watanabe, J; Yahagi, H | 1 |
| Averill, DB; Brosnihan, KB; Ferrario, CM; Gallagher, PE; Ishiyama, Y; Tallant, EA | 1 |
| Carey, RM | 1 |
| Gong, G; Hu, Q; Ishibashi, Y; Lee, J; Liu, J; Mansoor, A; Murakami, Y; Ochiai, K; Shimada, T; Wang, X; Zhang, J | 1 |
7 other study(ies) available for olmesartan medoxomil and Cardiovascular Stroke
| Article | Year |
|---|---|
Activation of renal angiotensin type 1 receptor contributes to the pathogenesis of progressive renal injury in a rat model of chronic cardiorenal syndrome.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Cardio-Renal Syndrome; Gene Expression; Imidazoles; Kidney; Male; Mineralocorticoid Receptor Antagonists; Myocardial Infarction; Nephrectomy; Olmesartan Medoxomil; Proteinuria; Rats; Receptor, Angiotensin, Type 1; Renin; Spironolactone; Tetrazoles | 2012 |
Beneficial effects of combination of ACE inhibitor and angiotensin II type 1 receptor blocker on cardiac remodeling in rat myocardial infarction.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Natriuretic Factor; Blotting, Northern; Collagen; Diastole; Drug Therapy, Combination; Echocardiography, Doppler; Imidazoles; Male; Models, Animal; Myocardial Infarction; Myocardium; Natriuretic Peptide, Brain; Olmesartan Medoxomil; Rats; Rats, Wistar; RNA, Messenger; Tetrazoles; Thiazepines; Ventricular Remodeling | 2003 |
Should increasing the dose or adding an AT1 receptor blocker follow a relatively low dose of ACE inhibitor initiated in acute myocardial infarction?
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Atrial Natriuretic Factor; Bradykinin; Collagen Type I; Collagen Type III; Drug Administration Schedule; Drug Therapy, Combination; Glyceraldehyde-3-Phosphate Dehydrogenases; Imidazoles; Male; Models, Animal; Myocardial Infarction; Myocardium; Norepinephrine; Olmesartan Medoxomil; Random Allocation; Rats; Rats, Wistar; RNA, Messenger; Tetrazoles; Thiazepines; Transforming Growth Factor beta; Ventricular Dysfunction, Left | 2003 |
[Fast and strong lowering of pressure. The newest sartan has passed the practice test].
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Arteriosclerosis; Diabetes Mellitus; Disease Models, Animal; Humans; Hypertension; Imidazoles; Myocardial Infarction; Olmesartan Medoxomil; Rabbits; Ramipril; Rats; Tetrazoles; Time Factors | 2003 |
Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors.
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Animals; Carboxypeptidases; Cardiomyopathy, Hypertrophic; Coronary Vessels; Disease Models, Animal; Enzyme Induction; Imidazoles; Ligation; Losartan; Male; Myocardial Infarction; Myocardium; Olmesartan Medoxomil; Peptide Fragments; Peptidyl-Dipeptidase A; Pyridines; Rats; Rats, Inbred Lew; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; RNA, Messenger; Tetrazoles; Ventricular Remodeling | 2004 |
Angiotensin type-1 receptor blockade increases ACE 2 expression in the heart.
Topics: Angiotensin I; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Animals; Carboxypeptidases; Down-Regulation; Enzyme Induction; Heart; Humans; Imidazoles; Losartan; Mice; Myocardial Infarction; Myocardium; Olmesartan Medoxomil; Peptide Fragments; Peptidyl-Dipeptidase A; Pyridines; Rats; Rats, Inbred Lew; Tetrazoles | 2004 |
Functional and bioenergetic consequences of AT1 antagonist olmesartan medoxomil in hearts with postinfarction LV remodeling.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Coronary Vessels; Energy Metabolism; Heart; Heart Failure; Imidazoles; Magnetic Resonance Spectroscopy; Mitochondria; Myocardial Infarction; Olmesartan Medoxomil; Oxygen Consumption; Phosphates; Proton-Translocating ATPases; Renin-Angiotensin System; Swine; Tetrazoles; Ventricular Remodeling | 2006 |